Bank of America initiated coverage on autonomous mobility company Pony Ai Inc (NASDAQ:PONY) with a “Buy” rating and a price ...
UBS analyst Ashwani Verma increased the price target for Teva Pharmaceutical Industries Ltd (NYSE:TEVA) to $30 from the previous $28 while keeping a Buy rating on the shares. Verma highlighted Teva as ...
Revenue decreased by 1.87% YoY & profit increased by 19.63% YoY, profit at ₹3805.94 crore and revenue at ₹127550.57 crore.